Endovascular treatment for basilar artery occlusion: a meta-analysis

Stroke and Vascular Neurology

article

Jiawen Xu¹  Xi Chen¹  Shidong Chen¹  Wenjie Cao¹  Hongchen Zhao¹  Wei Ni²  Yanrong Zhang³  Chao Gao²  Yuxiang Gu²  Xin Cheng¹  Yi Dong¹  Qiang Dong¹ 

[1] Department of Neurology , Huashan Hospital Fudan University;Department of Neurosurgery , Huashan Hospital Fudan University;Department of Nursing , Huashan Hospital Fudan University

关键词: Stroke;    Thrombectomy;    Thrombolytic Therapy;   

DOI  :  10.1136/svn-2022-001740

学科分类：社会科学、人文和艺术（综合）

来源: BMJ Publishing Group

【 摘 要 】

Acute basilar artery occlusion (BAO) maylead to severe disability or death in about 70%of patients.1 2 Previous studies have established endovascular treatment (EVT) as thestandard treatment for patients with acuteanterior circulation occlusions.3–9 However,the ideal effective treatment for acute BAOremains controversial.Two previously published randomisedcontrol studies (RCTs), BEST (Basilar ArteryOcclusion Endovascular Intervention versusStandard Medical Treatment) and BASICS(Basilar Artery International CooperationStudy), failed to achieve an advantage ofEVT over standard medical treatment (SMT).10 11 Recently, two other RCTs from China,ATTENTION (Endovascular Treatment ForAcute Basilar Artery Occlusion: A MulticentreRandomised Clinical Trial) and BAOCHE(Basilar Artery Occlusion Chinese Endovascular), were presented at the European StrokeOrganisation Conference 2022.

【 授权许可】

CC BY-NC|CC BY|CC BY-NC-ND